NLRP3 and inflammatory bowel disease: Aberrant activation of the NLRP3 inflammasome promotes the pathogenesis of inflammatory diseases, including chronic kidney disease, type II diabetes, atherosclerosis, neurodegenerative diseases, inflammatory bowel disease, gout, rheumatoid arthritis, cancers, and some infectious diseases (2).